For: | Paulino DSM, Mendes MCS, Camargo JA, Brambilla SR, Wood Dos Santos T, Ribeiro ML, Carvalheira JBC. Diacerein treatment prevents colitis-associated cancer in mice. World J Clin Oncol 2020; 11(9): 732-746 [PMID: 33033695 DOI: 10.5306/wjco.v11.i9.732] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/732.htm |
Number | Citing Articles |
1 |
Tourki A. S. Baokbah. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study. Journal of Histotechnology 2023; 46(1): 5 doi: 10.1080/01478885.2022.2129935
|
2 |
Mahmoud Elshal, Marwa E. Abdelmageed. Diacerein counteracts acetaminophen-induced hepatotoxicity in mice via targeting NLRP3/caspase-1/IL-1β and IL-4/MCP-1 signaling pathways. Archives of Pharmacal Research 2022; 45(3): 142 doi: 10.1007/s12272-022-01373-7
|
3 |
Supriya Roy, Suneela Dhaneshwar, Tarique Mahmood. Exploring the Potential of IL-1β Inhibitor Diacerein and its Combination
with 5-aminosalicylic Acid for the Possible Ameliorating Effect in TNBSinduced
Experimental Colitis in Wistar Rats. Current Drug Therapy 2022; 17(2): 132 doi: 10.2174/1574885517666220328142715
|